Breaks Categories: News

WednesdayJul 13, 2022 2:58 pm

NetworkNewsBreaks – Odyssey Health Inc. (ODYY) Featured in Stock2Me Podcast Spotlighting Two-Time Olympic Gold Medalist Abby Wambach

Odyssey Health (OTC: ODYY), formerly Odyssey Group International and a company focused on developing unique, life-saving medical products, is featured in the latest episode of InvestorBrandNetwork’s Stock2Me podcast. Hosted by Stuart Smith, the podcast talks with soccer play Abby Wambach, an Olympic gold medalist and member of ODYY’s sports advisory board. During the interview, Wambach discusses her soccer career and why she was drawn to Odyssey, a medical technology company that is developing a drug/device combination intended to treat concussion. Wambach and other members of the sports advisory board support the company’s efforts to enhance public awareness of traumatic brain…

Continue Reading

WednesdayJul 13, 2022 2:49 pm

NetworkNewsBreaks – American Rebel Holdings Inc. (NASDAQ: AREB) Closes $13M Private Placement

American Rebel (NASDAQ: AREB, AREBW), a designer and marketer of branded safes and personal security and self-defense products, has announced the closing of its private placement of common stock (or pre-funded warrants in lieu thereof) and warrants. Under the agreement, the company sold 11,711,712 shares of common stock (or pre-funded warrants in lieu thereof) and warrants to purchase 23,423,424 shares of common stock. Each share of common stock (or pre-funded warrant in lieu thereof) was sold together with accompanying warrants at a combined purchase price of $1.11. The warrants will be immediately exercisable from the date of issuance at an…

Continue Reading

WednesdayJul 13, 2022 2:45 pm

NetworkNewsBreaks – Bit Digital Inc. (NASDAQ: BTBT) Issues June 2022 Production Update

Bit Digital (NASDAQ: BTBT), a digital asset mining company headquartered in New York, has announced its unaudited bitcoin and ethereum production and corporate updates for the month of June 2022. According to the announcement, the company earned 67.6 bitcoins and 0.0 ETHs in June 2022. In addition, on June 30, 2022, Treasury holdings of BTC and ETH were 860.7 and 313.6, with a fair market value of approximately $17.0 million and $0.3 million, respectively. As of June 30, 2022, the company owned 38,135 bitcoin miners and 731 ethereum miners with an estimated maximum total hash rate of 2.7 EH/s and…

Continue Reading

WednesdayJul 13, 2022 2:39 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Nearing Start Date for Its Human Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the pending start of its upcoming human nicotine study NIC-H22-1. Through the study, Lexaria expects to evidence that processing purified nicotine with its patented drug delivery technology, DehydraTECH(TM), leads to enhanced oral-tissue absorption and reduced negative experiences. NIC-H22-1, a minimum 36-person human pharmacokinetic (“PK”) randomized, double blinded, cross-over study, will compare Lexaria’s DehydraTECH-nicotine pouch performance to that of existing leading brands currently sold in the U.S. such as ON! and Zyn. The primary objective of the study is data collection from blood samples that will evidence…

Continue Reading

WednesdayJul 13, 2022 2:32 pm

NetworkNewsBreaks – FSD Pharma Inc.’s (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) Lucid Psycheceuticals Files for Patent on Novel Formulations of Palmitoylethanolamide

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, today announced that is wholly owned subsidiary, Lucid Psycheceuticals Inc., filed a provisional patent application on novel formulations of palmitoylethanolamide (“PEA”). According to the update, the new patent application is based on the results of completed preclinical animal toxicology studies and phase 1 clinical trial using FSD201 (ultramicronized PEA), sponsored by FSD Pharma. The company is diligently pursuing the clinical development of FSD201 for various indications. FSD Pharma recently announced the submission of an Investigational New Drug…

Continue Reading

WednesdayJul 13, 2022 2:25 pm

NetworkNewsBreaks – Standard Lithium Ltd (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L) Releases Update on Key Developments

Standard Lithium (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L), an innovative technology and lithium project-development company, is reporting on recent corporate and project developments. Highlights of the update include additions to SLI management, a master service agreement (“MSA”) with Telescope Innovations (“TELI”), the progress of a DFS/FEED study award and increased shareholdings by senior management. Specifically, SLI named new positions and members to its management team, including Jason Tielker as vice president of project delivery and Angus Remfry as director of project delivery. In addition, the company is reviewing Pre-FEED deliverables related to its first commercial plant with the anticipation…

Continue Reading

WednesdayJul 13, 2022 2:11 pm

NetworkNewsBreaks – Friendable Inc.’s (FDBL) 360 Offering Sees Revenue Increases, General Artist Interest to Its FeaturedX Branded Service

Friendable (OTC: FDBL), a mobile technology and marketing company, today announced its six-month history following its acquisition of Artist Republik and FeaturedX brands/offerings. Upon these acquisitions, management has been focused on both, starting with Artist Republik, and has now just completed a phase II upgrade of FeaturedX, which the company attributes as the main contributing factor to revenue increases and ultimately surpassing the $168,000 mark from the acquisition to date. “It’s been our mission to provide a full 360 offering for all independent music artists and our team is convinced we have just that, and much more, from music distribution,…

Continue Reading

WednesdayJul 13, 2022 1:55 pm

NetworkNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) Completes Testing, Marks Milestone on Commercialization Path

Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F), a clean-technology company developing transformative power conversion technologies and control system solutions for next-generation EVs and electrical systems, announced that it has completed proof of concept testing designed to demonstrate the efficiencies of its 250kW 800V commercial prototype traction inverter. During the testing, the high-efficiency inverter showed reduction in switching losses of +90% compared to conventional, hard-switched inverters, which is a significant milestone for the company as it works toward commercialization. According to the announcement, a comparison of losses between soft-switching and hard-switching was calculated with Hillcrest’s system tested with 470V…

Continue Reading

TuesdayJul 12, 2022 4:45 pm

NetworkNewsBreaks – Silo Pharma Inc. (SILO) Announces Positive Results of New Study

Silo Pharma (OTCQB: SILO), a development-stage biopharmaceutical company, today announced that its novel liposomes reached a positive endpoint in animal studies showing effectiveness and reduced toxicity using a subcutaneous delivery method. “The successful results of our study show that the subcutaneous route of liposomal administration is well-suited for use in targeted drug delivery of anti-arthritic agents. We suggest that this drug delivery approach would not only enhance efficacy but also reduce systemic toxicity,” said Eric Weisblum, CEO of Silo Pharma. “In our previous work, ART-1-Cy7-liposomes injected i.v. demonstrated homing to arthritic joints and four hours was an optimal time point…

Continue Reading

TuesdayJul 12, 2022 4:38 pm

NetworkNewsBreaks – GSMI’s TA Week to Showcase Reimagined Processes to Engage, Secure Best Talent

Global Strategic Management Institute (“GSMI”), a cutting-edge conference production company focused on promoting disruptive innovation, will be hosting the upcoming Talent Acquisition (“TA”) Week in an entirely digital format between July 25-29, 2022. This July’s TA Week is set to feature three unique events in a single content-packed agenda, including the Social Recruiting Strategies Conference (“SRSC”), the Employer Branding Strategies Conference (“EBrandCon”), and the Talent Sourcing Strategies Summit (“TSSS”). An industry flagship forum catering to recruiting professionals, TA Week is designed to share comprehensive experiences to harness strategic improvements in sourcing, recruiting, and employer branding strategies and to build career-lasting…

Continue Reading